ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $2.98, $1.94 better than the analyst estimate of $1.04. Revenue for the quarter came in at $370.1 million versus the consensus estimate of $332.91 million.

Fourth Quarter 2017 Results

• Fourth quarter 2017 revenue was $370.1 million, compared to $95.7 million in the same period last year. GAAP gross profit for the fourth quarter of 2017 was $137.5 million, as compared to $50.8 million in the same period last year.
• GAAP gross margin for the fourth quarter of 2017 was 37%, as compared to 53% in the same period last year.
• GAAP net income for the fourth quarter of 2017 was $49.7 million, or $2.33 per diluted share, as compared to GAAP net income of $9.5 million, or $0.54 per diluted share, for the fourth quarter of 2016.
• Adjusted diluted earnings per share for the fourth quarter of 2017 were $2.98 as compared to $1.20 for the fourth quarter of 2016.
• Also, adjusted EBITDA was $70.1 million for the fourth quarter of 2017 as compared to $34.3 million for the fourth quarter of 2016.

Fiscal 2018 Guidance

The Company is modifying its full year 2018 adjusted earnings per share from a range of $6.05 to $6.65 to a range of $6.60 to $7.30.

GUIDANCE:

ICU Medical sees FY2018 EPS of $6.60-$7.30, versus the consensus of $6.61.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.